Home › Cancro (tutti i tipi) › Texas › San Antonio
Studi clinici su Cancro (tutti i tipi) a San Antonio, TX
41 studi su Cancro (tutti i tipi) cercano partecipanti presso sedi a San Antonio e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Study of ASP3082 in Adults With Advanced Solid Tumors
In reclutamentoFase 1
- NEXT Oncology, San Antonio
A Study of PHN-012 in Patients With Advanced Solid Tumors
In reclutamentoFase 1
- PHN-012-001 Site, San Antonio
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)
In reclutamentoFase 1
- South Texas Accelerated Research Therapeutics (START), San Antonio
Clinical Study of MK-4884 in Participants With Advanced or Metastatic Solid Tumors (MK-4884-001)
In reclutamentoFase 1
- NEXT Oncology ( Site 0151), San Antonio
A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)
In reclutamentoFase 2
- Mays Cancer Center ( Site 0039), San Antonio
First Time in Human (FTIH) Study to Investigate the Safety and Preliminary Activity of GSK5533524 Alone or in Combination in Adult Participants With Advanced Solid Tumors
In reclutamentoFase 1
- GSK Investigational Site, San Antonio
A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
In reclutamentoFase 1
- NEXT Oncology, San Antonio
Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)
In reclutamentoFase 3
- START San Antonio ( Site 0104), San Antonio
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
In reclutamentoFase 1/2
- NEXT Oncology San Antonio, San Antonio
- START Texas, San Antonio
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
In reclutamentoFase 2/3
- Sam Clinical Research Center, San Antonio
Multiple Dose Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases
In reclutamentoFase 1/2
- The Cancer Therapy and Research Center at UTHSCSA, San Antonio
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
In reclutamentoFase 1
- NEXT Oncology, San Antonio
Prostate Active Surveillance Study
In reclutamentoStudio osservazionale
- University of Texas Health Science Center, San Antonio, San Antonio
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
In reclutamentoFase 3
- Texas Oncology-San Antonio Cancer Care, San Antonio
- Texas Oncology - San Antonio Northeast, San Antonio
- Texas Oncology - San Antonio Stone Oak, San Antonio
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
In reclutamentoFase 1
- NEXT Oncology, San Antonio
Project: Every Child for Younger Patients With Cancer
In reclutamentoStudio osservazionale
- Children's Hospital of San Antonio, San Antonio
- Methodist Children's Hospital of South Texas, San Antonio
- University of Texas Health Science Center at San Antonio, San Antonio
Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies
In reclutamentoFase 1/2
- Site 01, San Antonio
FOG-001 in Locally Advanced or Metastatic Solid Tumors
In reclutamentoFase 1/2
- South Texas Accelerated Research Therapeutics, LLC, San Antonio
A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies
In reclutamentoFase 1
- NEXT Oncology San Antonio, San Antonio
- START- San Antonio, San Antonio
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
In reclutamentoFase 1/2
- UT Health Mays Cancer Center, San Antonio
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
In reclutamentoFase 1
- NEXT Oncology, San Antonio
A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid Tumors
In reclutamentoFase 1
- START San Antonio, San Antonio
IDOV-Immune for Advanced Solid Tumors
In reclutamentoFase 1
- South Texas Accelerated Research Therapeutics, San Antonio
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
In reclutamentoFase 3
- Texas Oncology San Antonio Medical Center, San Antonio
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
In reclutamentoFase 1
- START San Antonio, LLC., San Antonio
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
In reclutamentoFase 1
- NEXT Oncology, San Antonio
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
In reclutamentoFase 1
- USA Clinical Trials, San Antonio
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
In reclutamentoFase 1/2
- START San Antonio, San Antonio
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
In reclutamentoFase 1/2
- START, San Antonio
CT-95 in Advanced Cancers Associated With Mesothelin Expression
In reclutamentoFase 1
- Context Investigational Site, San Antonio
- Context Investigational Site, San Antonio
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
In reclutamentoFase 1
- Research Site #2, San Antonio
- Research Site, San Antonio
A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)
In reclutamentoFase 1
- GSK Investigational Site, San Antonio
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
In reclutamentoFase 1/2
- NEXT Oncology, San Antonio
Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors
In reclutamentoFase 1
- NEXT San Antonio, San Antonio
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
In reclutamentoFase 1
- NEXT Oncology San Antonio, San Antonio
An Open-Label Study of INV-1120 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors
In reclutamentoFase 1
- UT Health, San Antonio
A Study of YL242 in Subjects With Advanced Solid Tumors
In reclutamentoFase 1/2
- US-207, San Antonio
A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors.
In reclutamentoFase 1
- NEXT Oncology, San Antonio
Dose-escalation Study to Assess Safety and Pharmacokinetics of Nab-Sirolimus in Patients With Locally Advanced or Metastatic Solid Tumors and Moderate Liver Impairment
In reclutamentoFase 1
- South Texas Accelerated Research Therapeutics, LLC, San Antonio
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
In reclutamentoFase 1/2
- NEXT Oncology, San Antonio
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
In reclutamento
- University of Texas Health Science Center at San Antonio, San Antonio
Studi su Cancro (tutti i tipi) in altre città
- Houston, TX121 studi
- New York City, NY110 studi
- Boston, MA86 studi
- Los Angeles, CA73 studi
- Nashville, TN65 studi
- Philadelphia, PA59 studi
- Durham, NC58 studi
- Washington, DC58 studi
- Chicago, IL51 studi
- Seattle, WA49 studi
- Atlanta, GA49 studi
- Arlington, VA48 studi
Altri studi a San Antonio
- Cancro del polmone non a piccole cellule59 studi
- Cancro colorettale46 studi
- Cancro al seno46 studi
- Cancro metastatico44 studi
- Obesità40 studi
- Diabete di tipo 237 studi
- Sovrappeso34 studi
- Cancro ovarico31 studi
- Cancro pancreatico31 studi
- Cancro alla prostata28 studi
- Cancro dell'endometrio27 studi
- Cancro ai polmoni26 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.